Simplex Trading’s Fortress Biotech FBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.4K Sell
14,508
-43,821
-75% -$113K ﹤0.01% 6414
2026
Q1
$163K Buy
+58,329
New +$198K ﹤0.01% 4549
2025
Q4
Sell
-54,453
Closed -$155K 8976
2025
Q3
$201K Buy
+54,453
New +$138K ﹤0.01% 4929
2024
Q1
Sell
-1,762
Closed -$3.51K 9133
2023
Q4
$5K Buy
1,762
+1,427
+426% +$3.77K ﹤0.01% 7847
2023
Q3
$1K Sell
335
-707
-68% -$4.85K ﹤0.01% 8295
2023
Q2
$8K Buy
1,042
+758
+267% +$7.5K ﹤0.01% 7577
2023
Q1
$3K Buy
+284
New +$3.38K ﹤0.01% 8297
2022
Q1
Sell
-2,602
Closed -$71.2K 10670
2021
Q4
$97K Buy
+2,602
New +$116K ﹤0.01% 6293
2019
Q2
Sell
-90
Closed -$2K 7280
2019
Q1
$2K Sell
90
-43
-32% -$1.13K ﹤0.01% 6774
2018
Q4
$1K Buy
133
+4
+3% +$67 ﹤0.01% 6728
2018
Q3
$3K Sell
129
-104
-45% -$3.33K ﹤0.01% 6946
2018
Q2
$10K Buy
233
+173
+288% +$9.74K ﹤0.01% 6333
2018
Q1
$4K Buy
60
+56
+1,400% +$3.54K ﹤0.01% 4775
2017
Q4
$0 Sell
4
-99
-96% -$5.83K ﹤0.01% 6170
2017
Q3
$6K Buy
+103
New +$6.94K ﹤0.01% 4223
2017
Q1
Sell
-933
Closed -$41.7K 6314
2016
Q4
$37K Buy
933
+89
+11% +$3.33K ﹤0.01% 2443
2016
Q3
$37K Buy
844
+812
+2,538% +$34.5K ﹤0.01% 2368
2016
Q2
$1K Buy
32
+5
+19% +$233 ﹤0.01% 5270
2016
Q1
$1K Sell
27
-112
-81% -$4.73K ﹤0.01% 5078
2015
Q4
$5K Buy
+139
New +$5.83K ﹤0.01% 3858

Other funds holding FBIO

Simplex Trading's FBIO Position: Q2 2026 in Review

Simplex Trading reduced its Fortress Biotech (FBIO) stake by 75% in Q2 2026, selling an estimated $113K and leaving 14,508 shares worth $44.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6414.

Simplex Trading first reported a position in FBIO in Q4 2015 and has held it in 20 quarters since. The position peaked at $201K in Q3 2025. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Simplex Trading held 14,508 shares of Fortress Biotech worth $44.4K as of Q2 2026.
  • Simplex Trading sold 43,821 Fortress Biotech shares in Q2 2026, an estimated $113K.
  • Fortress Biotech made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6414 holding.
  • Simplex Trading first reported a position in Fortress Biotech in Q4 2015 and has held it in 20 quarters since.
  • Simplex Trading's Fortress Biotech position peaked at $201K in Q3 2025.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.